Wednesday, June 7, 2023
No Result
View All Result
  • বাংলা সংস্করণ
Shomporko
Advertisement
  • Home
  • News
    • Daily News
    • Feature
    • Sports
  • CANADA
    • Canada Daily
    • Community News
    • Canada Politics
    • Canada Economy
    • Canada Health
  • Global
  • Bangladesh
  • Interview
  • Article
    • Analytical
  • LITERATURE
    • Story
    • Poem
  • Opinion
    • Columnists
  • More
    • Food & Beverage
    • HISTORY
    • Kids Page
    • Travel
    • HOME DECOR
    • Video
    • Social Media
    • Festival
  • Home
  • News
    • Daily News
    • Feature
    • Sports
  • CANADA
    • Canada Daily
    • Community News
    • Canada Politics
    • Canada Economy
    • Canada Health
  • Global
  • Bangladesh
  • Interview
  • Article
    • Analytical
  • LITERATURE
    • Story
    • Poem
  • Opinion
    • Columnists
  • More
    • Food & Beverage
    • HISTORY
    • Kids Page
    • Travel
    • HOME DECOR
    • Video
    • Social Media
    • Festival
No Result
View All Result
Shomporko
No Result
View All Result
Home Uncategorized

Bangladeshi pharmaceutical company Globe Biotech wants to make the COVID vaccine available by Jan

by Shomporko
October 6, 2020
in Uncategorized
0
Bangladeshi pharmaceutical company Globe Biotech wants to make the COVID vaccine available by Jan
0
SHARES
22
VIEWS
Share on FacebookShare on Twitter

Guaranteeing that they have promising outcomes from pre-clinical trials on rabbits and mice of the coronavirus vaccine styled ‘BNCOVID’ developed by it, Bangladesh’s Globe Biotech Ltd on Monday said they need to carry it to the market by January next in the event that they are permitted to dispatch the first phase of human trials very soon.

The Bangladeshi pharmaceutical company said they have finished all the fundamental arrangements for making their vaccine activity a triumph, however, they said all that presently relies upon the administration’s collaboration in finishing the necessary cycles.

“We hope the government will stand beside us and assist us in every necessary area. If we all can make collective efforts, we hope, we’ll be able to start giving our vaccine to people across Bangladesh by January next,” Harunur Rashid, chairman of Globe Biotech, told a press conference at a city hotel.

He said pre-clinical trials suggest that their vaccine is as promising as the other leading corona vaccine candidates in the world. “If we can now make united efforts, we can export the vaccine to all over the world alongside meeting the local demand.”

Stating that the government has set aside Tk 10,000 crore for the corona vaccine, Harun said they will be able to earn over Tk 50,000 by exporting the BNCOVID vaccine if only the government extends the necessary support to them.

“Developing a vaccine is a daunting task. But our team worked hard and made an impossible job possible. We’ve built a cent percent foundation for the vaccine as we’re now at the stage of conducting phase-1 and phase-2 clinical trials,” he observed.

He urged the government and the regulatory body, including DGDA, to allow them to conduct the clinical trials of the vaccine as soon as possible. “We believe our vaccine will turn out to be one of the effective vaccines in the world and we’ll be able to save many lives. But we need government patronage to make it possible.”

Globe Biotech CEO Kakon Nag said their vaccine has already proved safe and effective in the pre-clinical trials on mice following an animal model and the results of the pre-clinical trial were published in the international platform, biorxive.org — an archive for unpublished pre-prints in life sciences.

“We’re now preparing the protocol for conducting a clinical trial of the vaccine together with Contract Research Organisation (CRO),” he said.

Kakon hoped that CRO will soon apply to the Bangladesh Medical Research Council (BMRC) with the protocol for getting the approval for the clinical trial of the vaccine.

Once they get the BMRC’s approval, he said, CRO will apply to the Directorate General of Drug Administration (DGDA) for permission to carry out the clinical trial.

Mentioning that Bangladesh is now witnessing the second wave of coronavirus, Kakon said recent studies recommend that D614G variant is cent percent responsible for it. “The BNCOVID vaccine developed with our own technology is the only and the first vaccine against the D614G variant.”

“We’ve done whatever necessary to bring an effective and safe vaccine to the market, but the further steps and final success depend on the cooperation of the government and the people of the country,” he observed.

Kakon said now their only responsibility is to provide vaccine doses for the clinical trial as per the protocol.

Asked whether they have any plan to conduct the trial of the vaccine in any other country, he said they are now focusing on trials only in Bangladesh as their primary target is to provide the BANCOVID here. “If we want to export the vaccine, then we may need to conduct the trial in other countries.”

The Globe Biotech CEO said they want to complete the trial within a short time by appointing a bigger number of volunteers as many people are contacting them to work as volunteers.

About the possible price of the vaccine, he said it is now difficult to say the exact price of it since their product does not reach the final stage. “But we can say it will be relatively cheaper.”

Speaking at the programme, Prof Mamun Al Mahtab, chairman of the hematology department at Bangabandhu Sheikh Mujib Medical University (BSMMU), said he hopes the BANCOVID will be an effective vaccine. “BANCOVID has just completed the preclinical stage. Even then, this vaccine may finally become unsuccessful. But we appreciate this imitative of Globe Biotech.”

BSMMU deputy registrar Dr. Sheikh Abdullah Al Mamun thanked Globe Biotech for making efforts for devolving the vaccine. “But you’ve to still go a long way to succeed.”

On July 2, Asif Mahmud, in-charge of research and development of Globe Biotech Limited, announced at a press conference that they were developing a Covid-19 vaccine as they completed preliminary animal trials successfully.

Photo credit: Collected

News source: UNB

Previous Post

Second wave killing fewer Canadians but is no reason to let down guard, doctors warn

Next Post

Canadians with COVID-19 or caring for those with it can apply for federal money Monday

Shomporko

Related Posts

Uncategorized

Cost of gas in the GTA could hit $2 a litre next month as Russian attack on Ukraine impacts oil prices: analyst

February 24, 2022
Uncategorized

Ontario proposes new law that will require employers to tell workers if they’re being electronically tracked

February 24, 2022
Uncategorized

Ontario reports 887 new COVID-19 cases, 3 more deaths

December 6, 2021
Uncategorized

Ontario reports 438 new COVID-19 cases, 5 more deaths

November 4, 2021
Parents more hesitant to vaccinate kids than themselves, researcher says
Uncategorized

Parents more hesitant to vaccinate kids than themselves, researcher says

October 24, 2021
Calgary Flames program to outfit Saskatchewan Indigenous minor hockey players with new equipment
Uncategorized

Calgary Flames program to outfit Saskatchewan Indigenous minor hockey players with new equipment

August 12, 2021
Next Post
Canadians with COVID-19 or caring for those with it can apply for federal money Monday

Canadians with COVID-19 or caring for those with it can apply for federal money Monday

Logo

Disclaimer:

The editorial team is not responsible for the content of the writing.

Publisher and Editor
Sonia Hoque

General Manager

Rewrite-Man

Reporter

Graphics
Mozammel Sarkar

Address:

Shomporko Magazine

59 Byng ave
Scarborough,
Ontario
M1L3N8

Phone :647-686-5432

 

Email: 
shomporko.magazine@gmail.com
2537765 Ontario Ltd

© 2020 Shomporko – Magazine Develop by RMITtech

No Result
View All Result
  • Home
  • NEWS
    • Daily News
    • Feature
    • Global
    • Politics
    • Sports
  • CANADA
    • Canada Daily
    • Community News
    • Canada Politics
    • Canada Economy
    • Canada Immigration
    • Canada Education
    • Canada Health
    • Canada Opinion
  • GLOBAL
  • INTERVIEW
  • ARTICLE
    • Analytical
  • LITERATURE
    • Story
    • Poem
  • OPINION
    • Opinion
    • Columnists
    • Legal Advice
  • ARTS
    • Home Decor
    • Sports
  • LIVING
    • Health
    • Food
    • Travel
    • HISTORY
    • Kids Page
  • MORE
    • Video
    • Social Media
    • Festival
  • বাংলা সংস্করণ

© 2019 Shomporko - Magazine Develop by RMITtech.

Translate »